Advertisement

Topics

$175.41 Million in Sales Expected for Emergent Biosolutions, Inc. (EBS) This Quarter

13:17 EST 11 Nov 2017 | Topix

Equities analysts predict that Emergent Biosolutions, Inc. will announce sales of $175.41 million for the current quarter, Zacks reports. Two analysts have provided estimates for Emergent Biosolutions' earnings, with the highest sales estimate coming in at $179.71 million and the lowest estimate coming in at $171.10 million.

Original Article: $175.41 Million in Sales Expected for Emergent Biosolutions, Inc. (EBS) This Quarter

NEXT ARTICLE

More From BioPortfolio on "$175.41 Million in Sales Expected for Emergent Biosolutions, Inc. (EBS) This Quarter"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...